Sutro Biopharma STRO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$38.48M+17.7% | -$46.76M+17.8% | -$56.86M-394% | -$11.5M+84.9% | -$75.97M-4.9% | ||
| $1.28M-21.3% | $1.62M-14.5% | $1.9M0.0% | $1.9M0.0% | $1.9M+1.7% | ||
| $1.56M-5.6% | $1.66M+6.6% | $1.55M-70.5% | $5.26M-5.0% | $5.54M-6.4% | ||
| -$42.26M-59.9% | -$26.44M+30.8% | -$38.19M+14.6% | -$44.72M+34.1% | -$67.88M+5.4% | ||
| $0— | —— | $47K— | —— | $27K— | ||
| -$45.26M-342% | $18.7M-53.2% | $39.99M+1,450% | $2.58M+116% | -$16.26M-119% | ||
| —— | —— | —— | —— | —— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $103.08M— | —— | $102K— | —— | $66K— | ||
| $15.55M+299% | -$7.8M— | $0+100% | -$42.2M+49.8% | -$84.08M-635% | ||
| -$42.26M-60.2% | -$26.38M+31.0% | -$38.24M+14.5% | -$44.72M+34.1% | -$67.91M+5.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Sutro Biopharma generate?
- Sutro Biopharma (STRO) generated -$151.6M in operating cash flow over the trailing twelve months.
- What is Sutro Biopharma's free cash flow?
- After $627.0K of capital expenditures, Sutro Biopharma's free cash flow was -$151.6M over the trailing twelve months, up 25.9% year over year.
- Where does Sutro Biopharma's cash flow data come from?
- Every line is extracted from Sutro Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
